VR Adviser, LLC

报告期 2026-03-31 · CIK 0001615982

持仓数

前50大市值合计

$2.68B

报告期

2026-03-31

当前持仓调仓

组合演变前 6 大持仓 + 其他逐季市值($B) · 点图或下方季度看该季调仓

看某季调仓:

26Q1 25Q4 25Q3 25Q2 25Q1 24Q4 24Q3 24Q2 24Q1 23Q4 23Q3 23Q2 23Q1 22Q4 22Q3 22Q2

24Q2 调仓2024-03-31 → 2024-06-30 · 共 24 项建仓 6增持 6减持 3清仓 9

方向

标的

Δ市值

现股数(环比)

建仓

ERAS ERASCA INC

+$38.3M

16,216,216

清仓

— HILLEVAX INC

-$34.5M

0 -100%

建仓

CGEM CULLINAN THERAPEUTICS INC

+$24.1M

1,379,965

调仓由相邻两季 13F 持仓相减推导(非逐笔成交);方向按股数增减,Δ市值受股价波动影响、符号可与方向相反;13F 申报滞后最长 45 天。

清仓

CELC CELCUITY INC

-$21.0M

0 -100%

增持

SYRE SPYRE THERAPEUTICS INC

-$19.2M

2,685,448 +24%

清仓

— IMMATICS N.V

-$18.4M

0 -100%

增持

— APPLIED THERAPEUTICS INC

-$17.1M

9,542,871 +5%

增持

— ENGENE HOLDINGS INC

-$16.8M

2,825,983 +10%

清仓

— LYRA THERAPEUTICS INC

-$16.0M

0 -100%

清仓

CGON CG ONCOLOGY INC

-$15.4M

0 -100%

增持

PRAX PRAXIS PRECISION MEDICINES I

-$13.9M

706,131 +0%

增持

COGT COGENT BIOSCIENCES INC

+$13.4M

5,684,167 +11%

减持

— ADVERUM BIOTECHNOLOGIES INC

-$11.9M

1,467,048 -6%

建仓

— PERCEPTIVE CAP SOLUTIONS COR

+$7.5M

750,000

清仓

MLYS MINERALYS THERAPEUTICS INC

-$7.2M

0 -100%

清仓

— ACELYRIN INC

-$6.3M

0 -100%

减持

— MERUS N V

-$5.9M

1,263,214 -29%

清仓

EYPT EYEPOINT PHARMACEUTICALS INC

-$5.2M

0 -100%

建仓

— ARCA BIOPHARMA INC

+$3.3M

866,375

减持

TRVI TREVI THERAPEUTICS INC

-$1.6M

3,422,637 -0%

清仓

OLMA OLEMA PHARMACEUTICALS INC

-$872.1K

0 -100%

建仓

— CASI PHARMACEUTICALS INC

+$614.3K

111,686

增持

IPSC CENTURY THERAPEUTICS INC

-$490.8K

5,389,259 +58%